365 related articles for article (PubMed ID: 27650916)
41. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
42. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
Ajmera VH; Terrault NA; Harrison SA
Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
[TBL] [Abstract][Full Text] [Related]
43. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.
Nakahara T; Hyogo H; Yoneda M; Sumida Y; Eguchi Y; Fujii H; Ono M; Kawaguchi T; Imajo K; Aikata H; Tanaka S; Kanemasa K; Fujimoto K; Anzai K; Saibara T; Sata M; Nakajima A; Itoh Y; Chayama K; Okanoue T;
J Gastroenterol; 2014 Nov; 49(11):1477-84. PubMed ID: 24277052
[TBL] [Abstract][Full Text] [Related]
44. Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study.
Rice BA; Naimi TS; Long MT
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2854-2863.e2. PubMed ID: 36503167
[TBL] [Abstract][Full Text] [Related]
45. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.
Lykiardopoulos B; Hagström H; Fredrikson M; Ignatova S; Stål P; Hultcrantz R; Ekstedt M; Kechagias S
PLoS One; 2016; 11(12):e0167776. PubMed ID: 27936091
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels.
Ulasoglu C; Enc FY; Kaya E; Yilmaz Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):427-431. PubMed ID: 31826068
[TBL] [Abstract][Full Text] [Related]
47. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
48. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.
Miyake T; Kumagi T; Hirooka M; Furukawa S; Yoshida O; Koizumi M; Yamamoto S; Watanabe T; Yamamoto Y; Tokumoto Y; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
J Gastroenterol; 2016 Nov; 51(11):1090-1100. PubMed ID: 26971094
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
[TBL] [Abstract][Full Text] [Related]
50. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
Önnerhag K; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
[TBL] [Abstract][Full Text] [Related]
51. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
[TBL] [Abstract][Full Text] [Related]
52. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.
Cengiz M; Ozenirler S; Kocabiyik M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):57-63. PubMed ID: 26513612
[TBL] [Abstract][Full Text] [Related]
53. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.
Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM
J Diabetes; 2015 Nov; 7(6):809-19. PubMed ID: 25350950
[TBL] [Abstract][Full Text] [Related]
54. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
Kaswala DH; Lai M; Afdhal NH
Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
[TBL] [Abstract][Full Text] [Related]
55. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).
Yaya I; Marcellin F; Costa M; Morlat P; Protopopescu C; Pialoux G; Santos ME; Wittkop L; Esterle L; Gervais A; Sogni P; Salmon-Ceron D; Carrieri MP;
Nutrients; 2018 May; 10(6):. PubMed ID: 29857547
[TBL] [Abstract][Full Text] [Related]
56. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
57. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.
Cengiz M; Ozenirler S
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023
[TBL] [Abstract][Full Text] [Related]
58. An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes.
Williams KH; Burns K; Constantino M; Shackel NA; Prakoso E; Wong J; Wu T; George J; McCaughan GW; Twigg SM
J Diabetes Complications; 2015; 29(8):1240-7. PubMed ID: 26297218
[TBL] [Abstract][Full Text] [Related]
59. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
60. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
Kistler KD; Brunt EM; Clark JM; Diehl AM; Sallis JF; Schwimmer JB;
Am J Gastroenterol; 2011 Mar; 106(3):460-8; quiz 469. PubMed ID: 21206486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
